{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T20:22:20Z","timestamp":1790713340548,"version":"4.1.0"},"reference-count":13,"publisher":"Walter de Gruyter GmbH","issue":"4","license":[{"start":{"date-parts":[[2021,9,17]],"date-time":"2021-09-17T00:00:00Z","timestamp":1631836800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"The University of Adelaiden\/a","award":["n\/a"],"award-info":[{"award-number":["n\/a"]}]},{"name":"The University of Adelaiden\/a","award":["n\/a"],"award-info":[{"award-number":["n\/a"]}]},{"name":"The Hospital Research Foundationn\/a","award":["n\/a"],"award-info":[{"award-number":["n\/a"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,12,20]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec id=\"j_pp-2021-0132_abs_001\">\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>Gastric cancer remains one of the most fatal cancers, despite an intensive treatment regime of chemotherapy\u2013surgery\u2013chemotherapy. Peritoneal metastatic disease is commonly diagnosed post treatment regime and once established, patients are likely to die in 3\u20139\u00a0months. Systemic chemotherapy does not increase survival for these patients due to the poor vascularisation of this area. We are proposing the addition of pressurised intraperitoneal aerosol chemotherapy (PIPAC) to the treatment regime for curative patients as a preventive measure to reduce the risk of peritoneal metastases occurring.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_pp-2021-0132_abs_002\">\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This is a prospective, single centre, non-randomised, open-label pilot trial evaluating the addition of PIPAC to the standard multimodal treatment pathway. Patients will undergo standard neoadjuvant chemotherapy with four cycles of fluorouracil, leucovorin, oxaliplatin and docetaxel (FLOT), then PIPAC, followed by gastrectomy. Four cycles of FLOT will be administered post-surgery. Primary outcome is safety and feasibility, assessed by perioperative morbidity and possible interruptions of the standard multimodal treatment pathway.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1515\/pp-2021-0132","type":"journal-article","created":{"date-parts":[[2021,9,16]],"date-time":"2021-09-16T16:09:48Z","timestamp":1631808588000},"page":"151-154","source":"Crossref","is-referenced-by-count":7,"title":["Can pressurised intraperitoneal aerosol chemotherapy with oxaliplatin (PIPAC-O+) be added to standard treatment for resectable high-risk gastric cancer patients? A study protocol"],"prefix":"10.1515","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8066-7259","authenticated-orcid":false,"given":"Jessica L.","family":"Reid","sequence":"first","affiliation":[{"name":"Discipline of Surgery , The University of Adelaide, The Queen Elizabeth Hospital , Adelaide , SA , Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harsh A.","family":"Kanhere","sequence":"additional","affiliation":[{"name":"Discipline of Surgery , The University of Adelaide, The Queen Elizabeth Hospital , Adelaide , SA , Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter J.","family":"Hewett","sequence":"additional","affiliation":[{"name":"Discipline of Surgery , The University of Adelaide, The Queen Elizabeth Hospital , Adelaide , SA , Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy J.","family":"Price","sequence":"additional","affiliation":[{"name":"Department of Oncology, The Queen Elizabeth Hospital , Adelaide , SA , Australia"},{"name":"Adelaide Medical School , The University of Adelaide , Adelaide , SA , Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guy J.","family":"Maddern","sequence":"additional","affiliation":[{"name":"Discipline of Surgery , The University of Adelaide, The Queen Elizabeth Hospital , Adelaide , SA , Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus I.","family":"Trochsler","sequence":"additional","affiliation":[{"name":"Discipline of Surgery , The University of Adelaide, The Queen Elizabeth Hospital , Adelaide , SA , Australia"},{"name":"Department of Surgery, Royal Adelaide Hospital , Adelaide , SA , Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"374","published-online":{"date-parts":[[2021,9,17]]},"reference":[{"key":"2025120909295125927_j_pp-2021-0132_ref_001","doi-asserted-by":"crossref","unstructured":"Alberto, M, Brandl, A, Garg, P, Gul-Klein, S, Dahlmann, M, Stein, U, et al.. Pressurized intraperitoneal aerosol chemotherapy and its effect on gastric-cancer-derived peritoneal metastases: an overview. Clin Exp Metastasis 2019;36:1\u201314. https:\/\/doi.org\/10.1007\/s10585-019-09955-4.","DOI":"10.1007\/s10585-019-09955-4"},{"key":"2025120909295125927_j_pp-2021-0132_ref_002","doi-asserted-by":"crossref","unstructured":"Lu, M, Yang, Z, Feng, Q, Yu, M, Zhang, Y, Mao, C, et al.. The characteristics and prognostic value of signet ring cell histology in gastric cancer: a retrospective cohort study of 2199 consecutive patients. Medicine 2016;95:e4052. https:\/\/doi.org\/10.1097\/md.0000000000004052.","DOI":"10.1097\/MD.0000000000004052"},{"key":"2025120909295125927_j_pp-2021-0132_ref_003","doi-asserted-by":"crossref","unstructured":"Al-Batran, S, Homann, N, Pauligk, C, Goetze, T, Meiler, J, Kasper, S, et al.. Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2\/3 trial. Lancet 2019;393:1948\u201357. https:\/\/doi.org\/10.1016\/s0140-6736(18)32557-1.","DOI":"10.1016\/S0140-6736(18)32557-1"},{"key":"2025120909295125927_j_pp-2021-0132_ref_004","doi-asserted-by":"crossref","unstructured":"Struller, F, Horvath, P, Solass, W, Weinreich, F, Strumberg, D, Kokkalis, M, et al.. Pressurized intraperitoneal aerosol chemotherapy with low-dose cisplatin and doxorubicin (PIPAC C\/D) in patients with gastric cancer and peritoneal metastasis: a phase II study. Ther Adv Med Oncol 2019;11:1758835919846402. https:\/\/doi.org\/10.1177\/1758835919846402.","DOI":"10.1177\/1758835919846402"},{"key":"2025120909295125927_j_pp-2021-0132_ref_005","doi-asserted-by":"crossref","unstructured":"Gockel, I, Jansen-Winkeln, B, Haase, L, Rhode, P, Mehdorn, M, Niebisch, S, et al.. Pressurized intraperitoneal aerosol chemotherapy (PIPAC) in gastric cancer patients with peritoneal metastasis (PM): results of a single-center experience and register study. J Gastric Canc 2018;18:379\u201391. https:\/\/doi.org\/10.5230\/jgc.2018.18.e37.","DOI":"10.5230\/jgc.2018.18.e37"},{"key":"2025120909295125927_j_pp-2021-0132_ref_006","doi-asserted-by":"crossref","unstructured":"Wagner, A, Syn, N, Moehler, M, Grothe, W, Yong, W, Tai, B, et al.. Chemotherapy for advanced gastric cancer. Cochrane Database Syst Rev 2017;8:CD004064. https:\/\/doi.org\/10.1002\/14651858.CD004064.pub4.","DOI":"10.1002\/14651858.CD004064.pub4"},{"key":"2025120909295125927_j_pp-2021-0132_ref_007","doi-asserted-by":"crossref","unstructured":"Cardona, K, Zhou, Q, Gonen, M, Shah, MA, Strong, VE, Brennan, MF, et al.. Role of repeat staging laparoscopy in locoregionally advanced gastric or gastroesophageal cancer after neoadjuvant therapy. Ann Surg Oncol 2013;20:548\u201354. https:\/\/doi.org\/10.1245\/s10434-012-2598-6.","DOI":"10.1245\/s10434-012-2598-6"},{"key":"2025120909295125927_j_pp-2021-0132_ref_008","doi-asserted-by":"crossref","unstructured":"Coccolini, F, Cotte, E, Glehen, O, Lotti, M, Poiasina, E, Catena, F, et al.. Intraperitoneal chemotherapy in advanced gastric cancer. Meta-analysis of randomized trials. Eur J Surg Oncol 2014;40:12\u201326. https:\/\/doi.org\/10.1016\/j.ejso.2013.10.019.","DOI":"10.1016\/j.ejso.2013.10.019"},{"key":"2025120909295125927_j_pp-2021-0132_ref_009","doi-asserted-by":"crossref","unstructured":"Kwon, O, Chung, H, Yu, W. Early postoperative intraperitoneal chemotherapy for macroscopically serosa-invading gastric cancer patients. Canc Res Treat 2014;46:270. https:\/\/doi.org\/10.4143\/crt.2014.46.3.270.","DOI":"10.4143\/crt.2014.46.3.270"},{"key":"2025120909295125927_j_pp-2021-0132_ref_010","doi-asserted-by":"crossref","unstructured":"Garg, PK, Jara, M, Alberto, M, Rau, B. The role of pressurized intraperitoneal aerosol chemotherapy in the management of gastric cancer: a systematic review. Pleura Peritoneum 2019;4:20180127. https:\/\/doi.org\/10.1515\/pp-2018-0127.","DOI":"10.1515\/pp-2018-0127"},{"key":"2025120909295125927_j_pp-2021-0132_ref_011","unstructured":"Mortensen, M. Adjuvant PIPAC in gastric cancer patients (PIPAC-OPC4). 2019. Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/record\/NCT04047004."},{"key":"2025120909295125927_j_pp-2021-0132_ref_012","doi-asserted-by":"crossref","unstructured":"Solass, W, Kerb, R, M\u00fcrdter, T, Giger-Pabst, U, Strumberg, D, Tempfer, C, et al.. Intraperitoneal chemotherapy of peritoneal carcinomatosis using pressurized aerosol as an alternative to liquid solution: first evidence for efficacy. Ann Surg Oncol 2014;21:553\u20139. https:\/\/doi.org\/10.1245\/s10434-013-3213-1.","DOI":"10.1245\/s10434-013-3213-1"},{"key":"2025120909295125927_j_pp-2021-0132_ref_013","doi-asserted-by":"crossref","unstructured":"Reymond, M, Solass, W, Nadiradze, G, Horvath, P, K\u00f6nigsrainer, A. Pressurized intraperitoneal aerosol chemotherapy (PIPAC). In: Fong, Y, Gamblin, T, Han, E, Lee, B, Zager, J, editors. Cancer regional therapy, HAI, HIPEC, HILP, ILI, PIPAC and beyond. Cham: Springer; 2020:235\u20136 pp. https:\/\/doi.org\/10.1007\/978-3-030-28891-4_20.","DOI":"10.1007\/978-3-030-28891-4_20"}],"container-title":["Pleura and Peritoneum"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/pp-2021-0132\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/pp-2021-0132\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T11:06:13Z","timestamp":1765278373000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/pp-2021-0132\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,17]]},"references-count":13,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2021,12,20]]},"published-print":{"date-parts":[[2021,12,20]]}},"alternative-id":["10.1515\/pp-2021-0132"],"URL":"https:\/\/doi.org\/10.1515\/pp-2021-0132","relation":{},"ISSN":["2364-768X"],"issn-type":[{"value":"2364-768X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,17]]}}}